{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:07:58Z","timestamp":1784012878710,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00520-026-10941-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:36:57Z","timestamp":1782790617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The application of continuous enteral nutrition during sequential chemoradiotherapy and immunotherapy in patients with esophageal cancer: a retrospective study"],"prefix":"10.1007","volume":"34","author":[{"given":"Yuan","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanqun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"10941_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/gastro\/gow013","volume":"4","author":"S Bharadwaj","year":"2016","unstructured":"Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanouneh I (2016) Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf) 4:272\u2013280. https:\/\/doi.org\/10.1093\/gastro\/gow013","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10941_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1442-2050.2012.01441.x","volume":"27","author":"JB Clavier","year":"2014","unstructured":"Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, Dufour P, Kurtz JE, Noel G (2014) Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis Esophagus 27:560\u2013567. https:\/\/doi.org\/10.1111\/j.1442-2050.2012.01441.x","journal-title":"Dis Esophagus"},{"key":"10941_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lungcan.2020.04.027","volume":"145","author":"FG Dall'Olio","year":"2020","unstructured":"Dall\u2019Olio FG, Maggio I, Massucci M, Mollica V, Fragomeno B, Ardizzoni A (2020) ECOG performance status \u22652 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-a systematic review and meta-analysis of real world data. Lung Cancer 145:95\u2013104. https:\/\/doi.org\/10.1016\/j.lungcan.2020.04.027","journal-title":"Lung Cancer"},{"key":"10941_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"10941_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ijrobp.2017.06.2457","volume":"99","author":"SR Francis","year":"2017","unstructured":"Francis SR, Orton A, Thorpe C, Stoddard G, Lloyd S, Anker CJ (2017) Toxicity and outcomes in patients with and without esophageal stents in locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 99:884\u2013894. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.2457","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10941_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030717","author":"M Hellerman Itzhaki","year":"2020","unstructured":"Hellerman Itzhaki M, Singer P (2020) Advances in medical nutrition therapy: parenteral nutrition. Nutrients. https:\/\/doi.org\/10.3390\/nu12030717","journal-title":"Nutrients"},{"key":"10941_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008229","author":"N Jiang","year":"2024","unstructured":"Jiang N, Zhang J, Guo Z, Wu Y, Zhao L, Kong C, Song X, Gu L, Zhao Y, Li S, He X, Ren B, Zhu X, Jiang M (2024) Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-008229","journal-title":"J Immunother Cancer"},{"key":"10941_CR8","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04025","volume":"14","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, Shu Y, Jiang Z, Zhang Y, Pan S, Jiang W, Liang J, Cheng X, Xu Z (2024) Burdens of stomach and esophageal cancer from 1990 to 2019 and projection to 2030 in China: findings from the 2019 Global Burden of Disease Study. J Glob Health 14:04025. https:\/\/doi.org\/10.7189\/jogh.14.04025","journal-title":"J Glob Health"},{"key":"10941_CR9","doi-asserted-by":"publisher","first-page":"16495","DOI":"10.1038\/s41598-024-67419-6","volume":"14","author":"Y Kong","year":"2024","unstructured":"Kong Y, Su M, Fang J, Chen M, Zheng C, Jiang Y, Tao K, Wang C, Qiu G, Ji Y, Wang Y, Yang Y (2024) Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy. Sci Rep 14:16495. https:\/\/doi.org\/10.1038\/s41598-024-67419-6","journal-title":"Sci Rep"},{"key":"10941_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02078-3","volume":"17","author":"H Li","year":"2022","unstructured":"Li H, Fang Y, Gu D, Du M, Zhang Z, Sun L, Zhou G, Ye J (2022) Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial. Radiat Oncol 17:105. https:\/\/doi.org\/10.1186\/s13014-022-02078-3","journal-title":"Radiat Oncol"},{"key":"10941_CR11","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1007\/s00262-023-03566-5","volume":"72","author":"N Li","year":"2023","unstructured":"Li N, Sohal D (2023) Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer. Cancer Immunol Immunother 72:3939\u20133952. https:\/\/doi.org\/10.1007\/s00262-023-03566-5","journal-title":"Cancer Immunol Immunother"},{"key":"10941_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M (2022) The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology 163:649-658.e642. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.054","journal-title":"Gastroenterology"},{"key":"10941_CR13","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1016\/j.clnu.2021.01.003","volume":"40","author":"S Movahed","year":"2021","unstructured":"Movahed S, Varshoee Tabrizi F, Pahlavani N, Seilanian Toussi M, Motlagh A, Eslami S, Ghayour-Mobarhan M, Nematy M, Ferns GA, Emadzadeh M, Khadem-Rezaiyan M, Alavi AH, Salek M, Zabeti P, Norouzy A (2021) Comprehensive assessment of nutritional status and nutritional-related complications in newly diagnosed esophageal cancer patients: a cross-sectional study. Clin Nutr 40:4449\u20134455. https:\/\/doi.org\/10.1016\/j.clnu.2021.01.003","journal-title":"Clin Nutr"},{"key":"10941_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.clon.2005.03.015","volume":"17","author":"C Odelli","year":"2005","unstructured":"Odelli C, Burgess D, Bateman L, Hughes A, Ackland S, Gillies J, Collins CE (2005) Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol (R Coll Radiol) 17:639\u2013645. https:\/\/doi.org\/10.1016\/j.clon.2005.03.015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10941_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00262-015-1725-1","volume":"64","author":"JD Phillips","year":"2015","unstructured":"Phillips JD, Knab LM, Blatner NR, Haghi L, DeCamp MM, Meyerson SL, Heiferman MJ, Heiferman JR, Gounari F, Bentrem DJ, Khazaie K (2015) Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer. Cancer Immunol Immunother 64:1185\u20131191. https:\/\/doi.org\/10.1007\/s00262-015-1725-1","journal-title":"Cancer Immunol Immunother"},{"key":"10941_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03847-4","volume":"25","author":"JC Preiser","year":"2021","unstructured":"Preiser JC, Arabi YM, Berger MM, Casaer M, McClave S, Montejo-Gonz\u00e1lez JC, Peake S, Reintam Blaser A, Van den Berghe G, van Zanten A, Wernerman J, Wischmeyer P (2021) A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice. Crit Care 25:424. https:\/\/doi.org\/10.1186\/s13054-021-03847-4","journal-title":"Crit Care"},{"key":"10941_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184632","author":"HC Puhr","year":"2021","unstructured":"Puhr HC, Preusser M, Ilhan-Mutlu A (2021) Immunotherapy for esophageal cancers: what is practice changing in 2021? Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13184632","journal-title":"Cancers (Basel)"},{"key":"10941_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1200\/JCO.2019.37.4_suppl.133","volume":"37","author":"SD Saeed","year":"2019","unstructured":"Saeed SD, Fontaine J, Pena L, Hoffe SE, Frakes J, Metha R, Gurd E, Pimiento JM (2019) Prognostic value of nutritional status for esophageal cancer patients undergoing neoadjuvant therapy and resection. J Clin Oncol 37:133\u2013133. https:\/\/doi.org\/10.1200\/JCO.2019.37.4_suppl.133","journal-title":"J Clin Oncol"},{"key":"10941_CR19","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00210-023-02781-2","volume":"397","author":"A Sharma","year":"2024","unstructured":"Sharma A, Jasrotia S, Kumar A (2024) Effects of chemotherapy on the immune system: implications for cancer treatment and patient outcomes. Naunyn Schmiedebergs Arch Pharmacol 397:2551\u20132566. https:\/\/doi.org\/10.1007\/s00210-023-02781-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10941_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285365","volume":"18","author":"N Takegawa","year":"2023","unstructured":"Takegawa N, Hirabayashi T, Tanaka S, Nishikawa M, Tokuyama N, Mimura T, Kushida S, Tsumura H, Yamamoto Y, Miki I, Tsuda M (2023) The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer. PLoS ONE 18:e0285365. https:\/\/doi.org\/10.1371\/journal.pone.0285365","journal-title":"PLoS ONE"},{"key":"10941_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.clnu.2014.12.002","volume":"34","author":"J Talvas","year":"2015","unstructured":"Talvas J, Garrait G, Goncalves-Mendes N, Rouanet J, Vergnaud-Gauduchon J, Kwiatkowski F, Bachmann P, Bouteloup C, Bienvenu J, Vasson MP (2015) Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: a double-blind randomized clinical trial. Clin Nutr 34:810\u2013817. https:\/\/doi.org\/10.1016\/j.clnu.2014.12.002","journal-title":"Clin Nutr"},{"key":"10941_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1002498","volume":"9","author":"WZ Xi","year":"2022","unstructured":"Xi WZ, Wu C, Liang YL, Wang LL, Cao YH (2022) Analysis of malnutrition factors for inpatients with chronic kidney disease. Front Nutr 9:1002498. https:\/\/doi.org\/10.3389\/fnut.2022.1002498","journal-title":"Front Nutr"},{"key":"10941_CR23","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.3892\/ol.2017.6759","volume":"14","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Li H, Yan C, Xu B, Hu R, Ma M, Wei H, Meng Y (2017) A comparative study on the efficacy of fast-track surgery in the treatment of esophageal cancer patients combined with metabolic syndrome. Oncol Lett 14:4812\u20134816. https:\/\/doi.org\/10.3892\/ol.2017.6759","journal-title":"Oncol Lett"},{"key":"10941_CR24","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.3390\/curroncol29090519","volume":"29","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Song R, Jia Y, Zhang X, Zhang S, Wu C, Zhang R, Guo Z (2022) Comparison of efficacy and safety of taxanes plus platinum and fluorouracil plus platinum in the first-line treatment of esophageal cancer: a systematic review and meta-analysis. Curr Oncol 29:6610\u20136627. https:\/\/doi.org\/10.3390\/curroncol29090519","journal-title":"Curr Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10941-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:46:16Z","timestamp":1784011576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10941-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10941"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10941-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Clinical Research Ethics Committee of Changzhou Second People\u2019s Hospital, Approval Number: [2021]KY117-01.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"704"}}